Deerfield Management announced a collaboration with Amazon Web Services (AWS) aiming to accelerate the development and scaling of AI-native healthcare and life sciences companies in its portfolio.
The partnership will connect AWS's generative AI and cloud services with Deerfield Intelligence's team of AI engineers and the innovation ecosystem of the firm's affiliate, Cure.
Deerfield aims to enable select companies from its portfolio to deploy agentic AI systems across drug discovery, operational automation and care delivery. The collaboration will also integrate AWS's AI services into the firm's research, evaluation, and operating processes.
Through the agreement, AWS will be designated as a preferred AI provider for Deerfield and selected portfolio companies, and its Intelligence, Discovery and Development (3DC) teams will receive access to AI and cloud technology from AWS, as well as technical support, to scale proprietary healthcare AI products and disseminate AI capabilities across interested companies in its portfolio.
Select Deerfield portfolio companies will also be provided access to AWS's AI and cloud technology, along with technical enablement and training on topics including large-scale model training, inference optimization, and healthcare-specific managed services.
The collaboration announcement follows similar agreements made between AWS and life sciences investment firms in 2026, including Flagship Pioneering and Sofinnova Partners.
"This collaboration aims to drive the development of the next generation of AI-powered healthcare organizations," said Dan Sheeran, Vice President and General Manager of Healthcare and Life Sciences at AWS, in a statement.
"With support from AWS, interested Deerfield portfolio companies can be equipped with AI services specific to supporting healthcare and life sciences needs like Amazon Bio Discovery, as well as agentic services like Amazon Bedrock AgentCore to build AI agents and support organizations at a scale that wouldn't have been feasible only a few years ago."
"Deerfield is working to build an ambitious AI-native platform in healthcare," added Jim Flynn, Managing Partner at Deerfield. "Our Intelligence team is developing models that aim to transform how we source opportunities, evaluate science, and accelerate portfolio companies. With access to AWS healthcare services, we hope to empower companies to accelerate their development timelines as they build their own clinical solutions."